Pictet Asset Management Holding Sa Blueprint Medicines Corp Transaction History
Pictet Asset Management Holding Sa
- $86.3 Billion
- Q1 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 954,596 shares of BPMC stock, worth $122 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
954,596
Previous 1,183,682
19.35%
Holding current value
$122 Million
Previous $103 Million
18.16%
% of portfolio
0.1%
Previous 0.12%
Shares
7 transactions
Others Institutions Holding BPMC
# of Institutions
391Shares Held
68.5MCall Options Held
1.54MPut Options Held
1.08M-
Black Rock Inc. New York, NY6.65MShares$849 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$849 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.42MShares$692 Million0.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.85MShares$492 Million5.51% of portfolio
-
Wellington Management Group LLP Boston, MA3.07MShares$393 Million0.05% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.63B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...